{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:12:46Z","timestamp":1762521166447},"reference-count":22,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1016\/j.ymgme.2007.05.013","type":"journal-article","created":{"date-parts":[[2007,7,3]],"date-time":"2007-07-03T07:13:55Z","timestamp":1183446835000},"page":"131-136","source":"Crossref","is-referenced-by-count":9,"title":["The outcome of clinical parameters in adults with severe Type I Gaucher disease using very low dose enzyme replacement therapy"],"prefix":"10.1016","volume":"92","author":[{"given":"Callum","family":"Wilson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Spearing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lochie","family":"Teague","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patsy","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilary","family":"Blacklock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2007.05.013_bib1","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"3635","article-title":"Gaucher disease","author":"Beutler","year":"2001"},{"key":"10.1016\/j.ymgme.2007.05.013_bib2","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0002-9343(02)01150-6","article-title":"Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry","volume":"113","author":"Weinreb","year":"2002","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ymgme.2007.05.013_bib3","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nm0596-523","article-title":"The Cost of treating Gaucher Disease","volume":"2","author":"Beutler","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymgme.2007.05.013_bib4","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/S0140-6736(95)91037-9","article-title":"Individualised low-dose alglucerase therapy for type 1 Gaucher\u2019s disease","volume":"345","author":"Hollak","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2007.05.013_bib5","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1006\/bcmd.2000.0310","article-title":"Comparative efficacy of dose regimens in enzyme replacement therapy of type I Gaucher disease","volume":"26","author":"Altarescu","year":"2000","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.ymgme.2007.05.013_bib6","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1182\/blood-2005-12-5072","article-title":"Superior effects of high-dose enzyme replacement therapy in type 1 Gaucher disease on bone marrow involvement and chitotriosidase levels: a 2-center retrospective analysis","volume":"108","author":"de Frost","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2007.05.013_bib7","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/01.GIM.0000153660.88672.3C","article-title":"Individualization of long-term enzyme replacement therapy for Gaucher disease","volume":"7","author":"Andersson","year":"2005","journal-title":"Genet Med."},{"key":"10.1016\/j.ymgme.2007.05.013_bib8","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/j.seminhematol.2004.07.009","article-title":"Therapeutic goals in the treatment of Gaucher disease","volume":"40","author":"Pastores","year":"2004","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.ymgme.2007.05.013_bib9","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/S0140-6736(95)91038-7","article-title":"Replacement therapy with imiglucerase for type 1 Gaucher\u2019s disease","volume":"345","author":"Zimran","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2007.05.013_bib10","first-page":"316","article-title":"Clinical and molecular aspects of Gaucher disease in New Zealand","volume":"110","author":"Woodfield","year":"1997","journal-title":"N. Z. Med. J."},{"key":"10.1016\/j.ymgme.2007.05.013_bib11","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1148\/radiol.2292020296","article-title":"Quantification of bone involvement in Gaucher disease: MR imaging bone marrow burden score as an alternative to Dixon quantitative chemical shift MR imaging--initial experience","volume":"229","author":"Maas","year":"2003","journal-title":"Radiology"},{"key":"10.1016\/j.ymgme.2007.05.013_bib12","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s002560100375","article-title":"Magnetic resonance imaging of bone marrow changes in Gaucher disease during enzyme replacement therapy: first German long-term results","volume":"30","author":"Poll","year":"2001","journal-title":"Skeletal Radiol."},{"key":"10.1016\/j.ymgme.2007.05.013_bib13","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s002560000276","article-title":"Bone marrow response in treated patients with Gaucher disease: evaluation by T1-weighted magnetic resonance images and correlation with reduction in liver and spleen volume","volume":"29","author":"Terk","year":"2000","journal-title":"Skeletal Radiol."},{"key":"10.1016\/j.ymgme.2007.05.013_bib14","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM199105233242104","article-title":"Replacement therapy for inherited enzyme deficiency\u2014macrophage-targeted glucocerebrosidase for Gaucher\u2019s disease","volume":"324","author":"Barton","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2007.05.013_bib15","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1006\/bcmd.1995.0012","article-title":"The clinical course of treated and untreated Gaucher disease. A study of 45 patients","volume":"21","author":"Beutler","year":"1995","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.ymgme.2007.05.013_bib16","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/ajh.2830470325","article-title":"Pathologic fractures may develop in Gaucher patients receiving enzyme replacement therapy","volume":"47","author":"Sidransky","year":"1994","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.ymgme.2007.05.013_bib17","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(95)91422-6","article-title":"Treatment regimens in Gaucher\u2019s disease","volume":"26","author":"Beutler","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2007.05.013_bib18","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1182\/blood-2003-11-3854","article-title":"Gaucher disease: alendronate disodium improves bone mineral density in adults receiving enzyme therapy","volume":"104","author":"Wenstrup","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2007.05.013_bib19","first-page":"977","article-title":"Chitotriosidase genotype and plasma activity in patients with type 1 Gaucher disease and their relatives (carriers and non carriers)","volume":"86","author":"Giraldo","year":"2001","journal-title":"Haematologica"},{"key":"10.1016\/j.ymgme.2007.05.013_bib20","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1023\/A:1008814105603","article-title":"The health-related quality of life of adults with Gaucher\u2019s disease receiving enzyme replacement therapy: results from a retrospective study","volume":"7","author":"Damiano","year":"1998","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.ymgme.2007.05.013_bib21","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1182\/blood-2006-03-010801","article-title":"Low-dose therapy trumps high-dose therapy again in the treatment of Gaucher disease","volume":"108","author":"Zimran","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2007.05.013_bib22","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1359\/jbmr.061004","article-title":"Effect of enzyme replacement therapy with imiglucerase on BMD in type 1 Gaucher disease","volume":"22","author":"Wenstrup","year":"2007","journal-title":"J. Bone Miner. Res."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719207001916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719207001916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,6]],"date-time":"2019-01-06T04:25:06Z","timestamp":1546748706000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719207001916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":22,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S1096719207001916"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2007.05.013","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}